After Memorial Sloan-Kettering Cancer Center in New York (one of the leading cancer care institutions in the country) decided not to use the colon cancer drug Zaltrap due to the drug’s price, manufacturer Sanofi announced that it would reduce the price of Zaltrap by about half. (The official price for Zaltrap has not been changed, but Sanofi will offer discounts of about 50%.)   Doctors from Sloan-Kettering claimed that the Zaltrap, Click here to read more…